Clinton HeraldHigh hopes & hype for experimental depression drug ketamineClinton HeraldLast year, Sanacora co-authored an American Psychiatric Association task force review of ketamine treatment for mood disorders that noted the benefits but said "major gaps" remain in knowledge about long-term effectiveness and safety. Most studies have ...Health Highlights: Oct. 31, 2018U.S. News & World Reportall 34 news articles »